Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,11 EUR | -0,47% | +5,50% | +38,36% |
28/03 | Transcript : Medigene AG, 2023 Earnings Call, Mar 28, 2024 | |
28/03 | Medigene AG geeft winstverwachting voor 2024 | CI |
Omzet 2023 * | 5,5 mln. 5,93 mln. | Omzet 2024 * | 11,5 mln. 12,39 mln. | Marktkapitalisatie | 51,83 mln. 55,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -18 mln. -19,4 mln. | Nettowinst (verlies) 2024 * | -12 mln. -12,93 mln. | EV/omzet 2023 * | 9,06 x |
Nettoliquiditeiten 2023 * | 2 mln. 2,16 mln. | Nettoschuld 2024 * | 17 mln. 18,32 mln. | EV/omzet 2024 * | 5,98 x |
K/w-verhouding 2023 * |
-2,67
x | K/w-verhouding 2024 * |
-5,34
x | Werknemers | 87 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 96,46% |
Recentste transcriptie over Medigene AG
1 dag | -0,47% | ||
1 week | +5,50% | ||
Lopende maand | +44,03% | ||
1 maand | +45,52% | ||
3 maanden | +47,04% | ||
6 maanden | +19,21% | ||
Lopend jaar | +38,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 25-07-22 |
Chief Tech/Sci/R&D Officer | - | 01-05-14 | |
René Goedkoop
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 66 | 12-08-16 | |
Frank Mathias
BRD | Director/Board Member | 62 | 15-05-18 |
Anthony Man
BRD | Director/Board Member | 68 | 16-12-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 2,11 | -0,47% | 123 601 |
27-03-24 | 2,12 | -10,17% | 56 527 |
26-03-24 | 2,36 | -13,24% | 171 348 |
25-03-24 | 2,72 | +15,74% | 234 877 |
22-03-24 | 2,35 | +17,50% | 191 378 |
uitgestelde koers Xetra, 28 maart 2024 om 17:36 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,36% | 55,98 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |